Seizure disorders Archives - MPR Wed, 17 Apr 2024 15:54:55 +0000 en-US hourly 1 https://wordpress.org/?v=6.4.3 https://www.empr.com/wp-content/uploads/sites/7/2023/03/cropped-empr-32x32.jpg Seizure disorders Archives - MPR 32 32 ACTHAR GEL https://www.empr.com/drug/acthar-gel/ Mon, 06 Feb 2023 21:00:52 +0000 https://www.empr.com/drug/h-p-acthar-gel/ Additional Administration Options Approved for Seizure Medication Xcopri https://www.empr.com/home/news/additional-administration-options-approved-for-seizure-medication-xcopri/ Thu, 11 Apr 2024 17:15:00 +0000 https://www.empr.com/?p=218609 The Food and Drug Administration (FDA) has approved 2 new administration options for Xcopri® (cenobamate tablets) for the treatment of adults with partial-onset seizures. 

Xcopri tablets can now either be swallowed whole or be crushed. The crushed tablet can be mixed with water and either administered by mouth as an oral suspension or administered via a nasogastric tube. 

The labeling update is supported by data from an open-label, randomized, single-center, 3-period, 6-sequence, balanced crossover study. Findings showed the plasma Cmax and AUC for Xcopri crushed tablets mixed in water, administered either orally or through a nasogastric tube, were similar to whole tablets.

“The approval addresses the needs of patients living with epilepsy who are currently taking, or who may benefit from starting Xcopri, but are unable to swallow the tablets whole,” said Louis Ferrari, BS, RPh, MBA, vice president, Medical Affairs at SK Life Science. “In some patients, crushing tablets offers an additional option for dosing and administration by nasogastric tube. This label update addresses an unmet need for this patient population and offers administration alternatives to the health care providers managing their care.”

Xcopri is available as 12.5mg-, 25mg-, 50mg-, 100mg-, 150mg-, and 200mg-strength tablets.

]]>
Antiepileptic Drug Indications https://www.empr.com/charts/antiepileptic-drug-indications/ Sat, 15 Sep 2018 18:39:42 +0000 https://www.empr.com/uncategorized/antiepileptic-drug-indications/ #articleColumn table.wkm ul li{padding: 0 0 10px 1em;}#articleColumn table.wkm p{ margin-bottom: 0;line-height: 120%;}.wkm-div {overflow: auto; }.wkm-SeeOnPhone { display: none; }thead.wkm {font-family: "Frutiger", "Verdana", "Helvetica", "Arial", sans-serif; font-weight: bold; font-size: 11px; font-style: normal; background-color: #D3DFE5; margin-top: 0; margin-bottom: 0; vertical-align: bottom; }tbody.wkm {font-family: "Frutiger", "Verdana", "Helvetica", "Arial", sans-serif; font-size: 11px; font-weight: normal; font-style: normal; line-height: 120% ; text-align: left; background-color: #F4F7F8; margin-top: 0; margin-bottom: 0; vertical-align: top; }tfoot.wkm {font-family: "Frutiger", "Verdana", "Helvetica", "Arial", sans-serif; font-size: 9px; font-weight: normal; font-style: normal; line-height: 120% ; text-align: left; background-color: #F4F7F8; margin-top: 0; margin-bottom: 0; vertical-align: top; }p.wkm-hang { margin-top: 0; margin-bottom: 0; margin-left: 1em; text-indent: -1em; }th.wkm-intro {font-family: "Frutiger", "Verdana", "Helvetica", "Arial", sans-serif; font-weight: normal; font-size: 11px; font-style: normal; vertical-align: bottom; text-align: left; line-height: 120% ; background-color: white; border: none; border-collapse: collapse; padding-top: 3px; padding-bottom: 3px; padding-right: 3px; padding-left: 3px; margin-top: 0; margin-bottom: 0; }.wkm-spannerlvl1left {font-family: "Frutiger", "Verdana", "Helvetica", "Arial", sans-serif; font-weight: bolder; font-size: 12px; line-height: 120% ; text-transform: uppercase ; border: none; padding-top: 3px; padding-bottom: 3px; padding-right: 3px; padding-left: 3px; background-color: #7091A1; color: white; text-align: left; }.wkm-spannerlvl2left {font-family: "Frutiger", "Verdana", "Helvetica", "Arial", sans-serif; font-weight: bolder; font-size: 12px; line-height: 120% ; border: none; padding-top: 3px; padding-bottom: 3px; padding-right: 3px; padding-left: 3px; background-color: #C0D1DA; color: black; text-align: left; }.wkm-spannerlvl3left {font-family: "Frutiger", "Verdana", "Helvetica", "Arial", sans-serif; font-weight: bolder; font-size: 11px; line-height: 120% ; border: none; padding-top: 3px; padding-bottom: 3px; padding-right: 3px; padding-left: 3px; background-color: #D3DFE5; color: black; text-align: left; }@media only screen and (max-width: 480px) { .wkm-SeeOnPhone { display: inline; } thead.wkm {font-family: "Frutiger", "Verdana", "Helvetica", "Arial", sans-serif; font-weight: bold; font-size: 12px; font-style: normal; background-color: #D3DFE5; margin-top: 0; margin-bottom: 0; vertical-align: bottom; } tbody.wkm {font-family: "Frutiger", "Verdana", "Helvetica", "Arial", sans-serif; font-size: 11px; font-weight: normal; font-style: normal; line-height: 120% ; text-align: left; background-color: #F4F7F8; margin-top: 0; margin-bottom: 0; vertical-align: top; } tfoot.wkm {font-family: "Frutiger", "Verdana", "Helvetica", "Arial", sans-serif; font-size: 10px; font-weight: normal; font-style: normal; line-height: 120% ; text-align: left; background-color: #F4F7F8; margin-top: 0; margin-bottom: 0; vertical-align: top; } p.wkm-hang { margin-top: 0; margin-bottom: 0; margin-left: .5em; text-indent: -.5em; } th.wkm-intro {font-family: "Frutiger", "Verdana", "Helvetica", "Arial", sans-serif; font-weight: normal; font-size: 11px; font-style: normal; vertical-align: bottom; text-align: left; line-height: 120% ; background-color: white; border: none; border-collapse: collapse; padding-top: 3px; padding-bottom: 3px; padding-right: 3px; padding-left: 3px; margin-top: 0; margin-bottom: 0; } .wkm-tchead { vertical-align: bottom; line-height: 120% ; text-align: left; border-top: none; border-bottom: none; border-left: none; border-right: none; border-collapse: collapse; padding-top: 1px; padding-bottom: 1px; padding-right: 0px; padding-left: 0px; font-weight: bold; font-size: 8px; font-stretch: ultra-condensed; background-color: #D3DFE5; margin-top: 0; margin-bottom: 0; vertical-align: bottom; } .wkm-spannerlvl1left {font-family: "Frutiger", "Verdana", "Helvetica", "Arial", sans-serif; font-weight: bolder; font-size: 12px; line-height: 120% ; text-transform: uppercase ; border: none; padding-top: 3px; padding-bottom: 3px; padding-right: 3px; padding-left: 3px; background-color: #7091A1; color: white; text-align: left; } .wkm-spannerlvl2left {font-family: "Frutiger", "Verdana", "Helvetica", "Arial", sans-serif; font-weight: bolder; font-size: 12px; line-height: 120% ; border: none; padding-top: 3px; padding-bottom: 3px; padding-right: 3px; padding-left: 3px; background-color: #C0D1DA; color: black; text-align: left; } .wkm-spannerlvl3left {font-family: "Frutiger", "Verdana", "Helvetica", "Arial", sans-serif; font-weight: bolder; font-size: 9px; line-height: 120% ; border: none; padding-top: 3px; padding-bottom: 3px; padding-right: 3px; padding-left: 3px; background-color: #D3DFE5; color: black; text-align: left; } }.wkm-straphead {font-family: "Frutiger", "Verdana", "Helvetica", "Arial", sans-serif; font-size: 14px; font-weight: bold; color: white; text-align: center; background-color: #557A8C; }table.wkm {border: none; border-collapse: collapse; }th.wkm-inside { vertical-align: bottom; line-height: 120% ; text-align: left; border-top: none; border-bottom: none; border-left: 2px dotted gray; border-right: 2px dotted gray; border-collapse: collapse; padding-top: 3px; padding-bottom: 3px; padding-right: 3px; padding-left: 3px; }th.wkm-tchead { vertical-align: bottom; line-height: 120% ; text-align: left; border-top: none; border-bottom: none; border-left: none; border-right: none; border-collapse: collapse; padding-top: 1px; padding-bottom: 1px; padding-right: 0px; padding-left: 0px; font-weight: bold; font-size: 9.5px; font-stretch: ultra-condensed; background-color: #D3DFE5; margin-top: 0; margin-bottom: 0; vertical-align: bottom; } th.wkm { vertical-align: bottom; line-height: 120% ; text-align: left; border-top: none; border-bottom: none; border-left: none; border-right: none; border-collapse: collapse; padding-top: 3px; padding-bottom: 3px; padding-right: 3px; padding-left: 3px; }td.wkm-first { border-top: none; border-bottom: none; border-left: none; border-collapse: collapse; padding-top: 3px; padding-bottom: 3px; padding-right: 3px; padding-left: 3px; }td.wkm-first { border-top: none; border-bottom: none; border-left: none; border-collapse: collapse; padding-top: 3px; padding-bottom: 3px; padding-right: 3px; padding-left: 3px; }td.wkm-inside { border-top: none; border-bottom: none; border-left: 2px dotted gray; border-right: 2px dotted gray; border-collapse: collapse;padding-top: 3px; padding-bottom: 3px; padding-right: 3px; padding-left: 3px; }td.wkm-last { border-top: none; border-bottom: none; border-left: 2px dotted gray; border-right: none; border-collapse: collapse; padding-top: 3px; padding-bottom: 3px; padding-right: 3px; padding-left: 3px; }td.wkm-first-topdotted { border-top: 2px dotted gray; border-bottom: 1px solid black; border-left: none; border-right: 2px dotted gray; border-collapse: collapse; padding-top: 3px; padding-bottom: 3px; padding-right: 3px; padding-left: 3px; }td.wkm-inside-topdotted { border-top: 2px dotted gray; border-bottom: none; border-left: 2px dotted gray; border-right: 2px dotted gray; border-collapse: collapse; padding-top: 3px; padding-bottom: 3px; padding-right: 3px; padding-left: 3px; }td.wkm-last-topdotted { border-top: 2px dotted gray; border-bottom: none; border-left: 2px dotted gray; border-right: none; border-collapse: collapse; padding-top: 3px; padding-bottom: 3px; padding-right: 3px; padding-left: 3px; }td.wkm-first-topdashed { border-top: 2px dashed b7b7b7; border-bottom: none; border-left: none; border-right: 2px dotted gray; border-collapse: collapse; padding-top: 3px; padding-bottom: 3px; padding-right: 3px; padding-left: 3px; }td.wkm-inside-topdashed { border-top: 2px dashed #b7b7b7; border-bottom: none; border-left: 2px dotted gray; border-right: 2px dotted gray; border-collapse: collapse; padding-top: 3px; padding-bottom: 3px; padding-right: 3px; padding-left: 3px; }td.wkm-topdashed { border-top: 2px dashed #b7b7b7; border-bottom: none; border-left: 2px dotted gray; border-right: 2px dotted gray; border-collapse: collapse; padding-top: 3px; padding-bottom: 3px; padding-right: 3px; padding-left: 3px; }td.wkm-last-topdashed { border-top: 2px dashed #b7b7b7; border-bottom: none; border-left: 2px dotted gray; border-right: none; border-collapse: collapse; padding-top: 3px; padding-bottom: 3px; padding-right: 3px; padding-left: 3px; }td.wkm-foot-bot { border-top: none; border-bottom: 4px solid #C0D1DA; border-left: none; border-right: none; border-collapse: collapse; padding-top: 3px; padding-bottom: 3px; padding-right: 3px; padding-left: 3px; }td.wkm-foot { border-top: none; border-bottom: none; border-left: none; border-right: none; border-collapse: collapse; padding-top: 3px; padding-bottom: 3px; padding-right: 3px; padding-left: 3px; }td.wkm-list { border-top: none; border-bottom: none; border-left: none; border-right: none; border-collapse: collapse; padding-top: 3px; padding-bottom: 3px; padding-right: 3px; padding-left: 3px; }td.wkm { border-top: none; border-bottom: none; border-left: 2px dotted gray; border-right: 2px dotted gray; border-collapse: collapse; padding-top: 3px; padding-bottom: 3px; padding-right: 3px; padding-left: 3px; }p.wkm-sub-hang { margin-top: 0; margin-bottom: 0; margin-left: 3.1em; text-indent: -1em; padding-bottom: 0px; }p.wkm-foot-hang { margin-top: 0!important; margin-bottom: 0!important; margin-left: 1em!important; text-indent: -1em!important; padding-bottom: 0px!important;font-family: "Frutiger", "Verdana", "Helvetica", "Arial", sans-serif!important; font-size: 10px!important; font-weight: normal; font-style: normal; line-height: 130%!important; text-align: left;}p.wkm-foot { margin-top: 0!important; margin-bottom: 0!important; padding-bottom: 0px!important; font-family: "Frutiger", "Verdana", "Helvetica", "Arial", sans-serif!important; font-size: 10px!important; font-weight: normal; font-style: normal; line-height: 130%!important; text-align: left;}p.wkm-revision { font-size: 9px!important; text-align: right!important; margin-top: 0!important; margin-bottom: 0!important; padding-bottom: 0px!important; }p.wkm-bit-of-space { font-size: 5px!important; line-height: 25% !important; margin-top: 0!important; margin-bottom: 0!important; padding-bottom: 0px!important; }p.wkm { margin-top: 0; margin-bottom: 0; margin-right: 0; margin-left: 0; text-indent: 0; padding-bottom: 0px; }.wkm-brand { font-weight: bold;font-size: 11px;}.wkm-bold { font-weight: bold; }.wkm-company { font-style: italic; font-weight: normal; }.wkm-spannernotehead {font-family: "Frutiger", "Verdana", "Helvetica", "Arial", sans-serif; font-weight: bold; font-size: 12px; line-height: 120% ; border: none; padding-top: 3px; padding-bottom: 3px; padding-right: 3px; padding-left: 3px; background-color: #7091A1; color: white; text-align: left; }

Antiepileptic Drug Indications

ANTIEPILEPTIC DRUG INDICATIONS
Partial Generalized
Generic Brand Form Simple Complex Absence Myoclonic Tonic-clonic Atonic Mixed Status Epilepticus Lennox-Gastaut Others7
Adrenocorticotropic Hormone (Acth) Analogue
corticotrophin H.P. Acthar Gel ℞ gel for IM, SC inj √
Alpha-2 Delta Ligand
pregabalin Lyrica CV caps, oral susp √1 √1
AMPA GLUTAMATE RECEPTOR ANTAGONIST
perampanel Fycompa CIII tabs, oral susp √ √ √1
ANTIEPILEPTICS
brivaracetam Briviact CV tabs, oral soln, IV inj √ √
cenobamate Xcopri CV tabs √ √
divalproex sodium Depakote ℞ del-rel tabs √ √ √1
Depakote ER ℞ ext-rel tabs √ √ √1
Depakote Sprinkle ℞ del-rel coated particles in caps √ √ √1
gabapentin Neurontin ℞ caps, tabs, oral soln √1 √1
levetiracetam Keppra ℞ tabs, oral soln, IV inj √ √ √1 √1
Keppra XR ℞ ext-rel tabs √ √
Spritam ℞ tabs for oral susp √ √ √1 √1
rufinamide Banzel ℞ tabs, oral susp √1
stiripentol Diacomit ℞ caps, oral susp √
valproate sodium — ℞ IV inj √2 √2 √1,2
valproic acid — ℞ caps, syrup √ √ √1
vigabatrin Sabril ℞ tabs, pwd for oral soln √1,3 √
BARBITURATE
phenobarbital Sezaby CIV IV inj √
primidone Mysoline ℞ tabs √ √ √
BENZODIAZEPINE
clobazam Onfi CIV tabs, oral soln √1
Sympazan CIV oral films √1
clonazepam — CIV ODT √3 √ √ √
Klonopin CIV tabs √3 √ √ √
diazepam — CIV IM, IV inj √1 √1
oral soln √1 √1 √1 √1 √1,5 √1 √1 √1
Diastat CIV rectal gel √
Diazepam Intensol CIV oral soln √1 √1 √1 √1 √1,5 √1 √1 √1
Valium CIV tabs √1 √1 √1 √1 √1,5 √1 √1 √1
Valtoco CIV nasal spray √
lorazepam Ativan CIV IM, IV inj √
midazolam Nayzilam CIV nasal spray √
Seizalam CIV IM inj √
CANNABINOID
cannabidiol Epidiolex CV oral soln √ √
DIBENZAZEPINE
carbamazepine Carbatrol ℞ ext-rel caps √ √ √ √
Equetro ℞ ext-rel caps √ √ √
Tegretol ℞ tabs, oral susp √ √ √ √
Tegretol XR ℞ ext-rel tabs √ √ √ √
eslicarbazepine Aptiom ℞ tabs √ √
oxcarbazepine Oxtellar XR ℞ ext-rel tabs √ √
Trileptal ℞ tabs, oral susp √ √
GABAA RECEPTOR MODULATOR
ganaxolone Ztalmy CV oral susp √
HYDANTOIN
fosphenytoin Cerebyx ℞ IV, IM inj √2 √2 √6 √
phenytoin — ℞ IV inj √6 √
Dilantin ℞ ext-rel caps, oral susp √ √ √
Dilantin Infatabs ℞ chew tabs √ √ √
Phenytek ℞ ext-rel caps √ √ √
PHENYLTRIAZINE
lamotrigine Lamictal ℞ tabs, chew tabs, ODT √1,4 √1,4 √1 √1
Lamictal XR  ℞ ext-rel tabs √1,4 √1,4 √1
SODIUM CHANNEL INACTIVATOR
lacosamide Vimpat CV tabs, oral soln, IV inj √ √ √1
SUCCINIMIDE
ethosuximide Zarontin ℞ caps, syrup √
methsuximide Celontin ℞ caps √3
SULFAMATE
topiramate — ℞ coated beads in caps √ √ √ √1
Eprontia ℞ oral soln √ √ √ √1
Qudexy XR ℞ ext-rel caps √ √ √ √1
Topamax ℞ caps, tabs √ √ √ √1
Trokendi XR ℞ ext-rel caps √ √ √ √1
SULFONAMIDE
zonisamide Zonegran ℞ caps √1 √1
SYMPATHOMIMETIC
fenfluramine Fintepla CIV oral soln √ √
NOTES

Key: AED = antiepileptic drug; del-rel = delayed-release; ext-rel = extended-release; ODT = orally-disintegrating tablets

1 Adjunct therapy only.

2 Temporary alternative to oral therapy.

3 Only if refractory to other therapy.

4 Conversion to monotherapy in adults with partial seizures who are on a single AED (see full labeling).

5 Also indicated for tonic seizure.

6 For generalized tonic-clonic status epilepticus.

7 Other indications include infantile spasms, neonatal seizures, Dravet syndrome, recurrent seizures, multiple seizure types, cluster seizures (episodes of increased seizure activity), neurosurgically-induced seizures, seizures due to cyclin-dependent kinase-like 5 (CDKL5) deficiency disorder; see full labeling.

Not an inclusive list of medications and/or official indications. Please see drug monograph at www.eMPR.com and/or contact company for full drug labeling.

(Rev. 6/2023)

]]>
APTIOM https://www.empr.com/drug/aptiom/ Thu, 22 Jul 2021 11:32:33 +0000 https://www.empr.com/drug/aptiom/ APTIOMEslicarbazepine acetate 200mg+, 400mg, 600mg+, 800mg+; (+) scored tabs.]]> APTIOM]]> ATIVAN INJECTION https://www.empr.com/drug/ativan-injection/ Fri, 17 Feb 2023 16:02:30 +0000 https://www.empr.com/drug/ativan-injection/ BANZEL https://www.empr.com/drug/banzel/ Thu, 22 Jul 2021 11:06:40 +0000 https://www.empr.com/drug/banzel/ BANZELRufinamide 200mg, 400mg; scored tabs.]]> BANZEL]]> BANZEL ORAL SUSPENSION https://www.empr.com/drug/banzel-oral-suspension/ Thu, 22 Jul 2021 11:17:24 +0000 https://www.empr.com/drug/banzel-oral-suspension/ BANZEL ORAL SUSPENSIONRufinamide 40mg/mL; orange-flavor; lactose-, gluten-, and dye-free.]]> BANZEL ORAL SUSPENSION]]> BRIVIACT https://www.empr.com/drug/briviact/ Thu, 01 Jun 2023 18:31:31 +0000 https://www.empr.com/drug/briviact/ BRIVIACT INJECTION https://www.empr.com/drug/briviact-injection/ Wed, 01 Sep 2021 18:50:21 +0000 https://www.empr.com/drug/briviact-injection/ BRIVIACT ORAL SOLUTION https://www.empr.com/drug/briviact-oral-solution/ Wed, 01 Sep 2021 18:50:45 +0000 https://www.empr.com/drug/briviact-oral-solution/ Carbamazepine Dosing https://www.empr.com/calculators/carbamazepine-dosing/ Thu, 04 Feb 2016 02:25:05 +0000 https://www.empr.com/uncategorized/carbamazepine-dosing/ Start Over

Start Over

]]>
CARBATROL https://www.empr.com/drug/carbatrol/ Mon, 01 May 2023 19:51:38 +0000 https://www.empr.com/drug/carbatrol/ CELONTIN https://www.empr.com/drug/celontin/ Thu, 22 Jul 2021 11:30:04 +0000 https://www.empr.com/drug/celontin/ CEREBYX https://www.empr.com/drug/cerebyx/ Thu, 22 Jul 2021 11:15:02 +0000 https://www.empr.com/drug/cerebyx/ Clonazepam Orally-Disintegrating Tabs https://www.empr.com/drug/clonazepam-orally-disintegrating-tabs/ Fri, 17 Feb 2023 17:37:25 +0000 https://www.empr.com/drug/clonazepam-orally-disintegrating-tabs/ Corrected Phenytoin (Albumin) https://www.empr.com/calculators/corrected-phenytoin-albumin/ Wed, 03 Feb 2016 20:42:27 +0000 https://www.empr.com/uncategorized/corrected-phenytoin-albumin/ Start Over

Start Over

]]>
DEPAKOTE https://www.empr.com/drug/depakote/ Mon, 13 Mar 2023 18:33:43 +0000 https://www.empr.com/drug/depakote/ DEPAKOTE ER https://www.empr.com/drug/depakote-er/ Mon, 13 Mar 2023 18:34:50 +0000 https://www.empr.com/drug/depakote-er/ DEPAKOTE ERDivalproex sodium 250mg, 500mg; ext-rel tabs.]]> DEPAKOTE ER]]> DEPAKOTE SPRINKLE https://www.empr.com/drug/depakote-sprinkle/ Mon, 13 Mar 2023 18:34:25 +0000 https://www.empr.com/drug/depakote-sprinkle/ DEPAKOTE SPRINKLEDivalproex sodium 125mg; coated particles in caps.]]> DEPAKOTE SPRINKLE]]> DIACOMIT https://www.empr.com/drug/diacomit/ Tue, 16 Aug 2022 13:21:53 +0000 https://www.empr.com/drug/diacomit/ DIACOMIT ORAL SUSP https://www.empr.com/drug/diacomit-oral-susp/ Tue, 16 Aug 2022 13:22:35 +0000 https://www.empr.com/drug/diacomit-oral-susp/ DIASTAT https://www.empr.com/drug/diastat/ Thu, 23 Feb 2023 20:33:42 +0000 https://www.empr.com/drug/diastat/ Diazepam Injection https://www.empr.com/drug/diazepam-injection/ Fri, 17 Feb 2023 19:51:34 +0000 https://www.empr.com/drug/diazepam-injection/ Diazepam Intensol https://www.empr.com/drug/diazepam-intensol/ Thu, 23 Feb 2023 20:18:23 +0000 https://www.empr.com/drug/diazepam-intensol/ Diazepam Oral Solution https://www.empr.com/drug/diazepam-oral-solution/ Thu, 23 Feb 2023 20:18:06 +0000 https://www.empr.com/drug/diazepam-oral-solution/